首页/行业动态/论文详情

肠道乳腺轴介导的改善唾液酸牛奶寡糖合成黄精多糖和益生菌与妊娠代谢障碍小鼠

Gut-Mammary Axis-Mediated Improvement of Sialylated Milk Oligosaccharide Synthesis by Polygonatum sibiricum Polysaccharide and Probiotics in Mice with Gestational Metabolic Disorders.

科研进展PubMed 论文(功能食品)机译
  • 期刊Journal of agricultural and food chemistry(J Agric Food Chem)
  • 发表时间2026-10-28
  • 作者Wang Y, Kang YL, Rui BQ, Zhao J, Zhou ML, E QY, Walayat B, Pan T, Zheng Y, Zhang XM, Liu YH, Yan JY, 等
  • 卷期页码V74(42) : 33028-33044
  • DOI10.1021/acs.jafc.6c08273
  • PMID42949316

摘要机译

牛奶低聚糖(MOs)对婴儿健康至关重要,但容易受到妊娠代谢功能障碍的影响。为了探索一种新的微生态干预策略,我们建立了益生菌发酵平台,结合乳腺上皮细胞筛选模型,以确定黄精多糖(PSP)作为有前途的候选者。

小鼠模型表明PSP单一疗法和协同治疗与益生菌大大减轻妊娠代谢紊乱和恢复产后唾液酸MOs。

机制上,联合治疗优于单一干预调节甘油磷脂(GPL)和多不饱和脂肪酸(PUFA)代谢,减轻乳腺线粒体功能障碍和ATP缺乏,并显著上调唾液酸转移酶基因ST3GAL1的mRNA表达。

值得注意的是,ATP恢复改善了前体可用性,而ST3GAL1上调促进了末端唾液酸化,共同促进唾液酸化MO生物合成。我们的研究结果为母亲代谢健康如何通过肠道-乳腺轴控制唾液酸化MO生物合成提供了新的见解,并提出了针对妊娠代谢紊乱的协同微生态干预策略。

展开英文摘要原文

Milk oligosaccharides (MOs) are vital for infant health but vulnerable to gestational metabolic dysfunction. To explore a new microecological intervention strategy, we established a probiotic fermentation platform coupled with a mammary epithelial cell screening model to identify Polygonatum sibiricum polysaccharide (PSP) as a promising candidate. Murine models demonstrated that both PSP monotherapy and synergistic treatment with probiotics significantly mitigated gestational metabolic dysregulation and restored postpartum sialylated MOs. Mechanistically, the combined treatment outperformed single interventions by modulating glycerophospholipid (GPL) and polyunsaturated fatty acid (PUFA) metabolism, mitigating mammary gland mitochondrial dysfunction and ATP deficiency, and significantly upregulating the mRNA expression of sialyltransferase gene ST3GAL1. Notably, ATP restoration improved precursor availability, while ST3GAL1 upregulation promoted terminal sialylation, jointly facilitating sialylated MO biosynthesis. Our findings provide novel insights into how maternal metabolic health governs sialylated MO biosynthesis via the gut-mammary gland axis and propose a synergistic microecological intervention strategy for gestational metabolic disorders.

相关物质

PubMed 原文 ↗DOI 入口 ↗

本页由系统自动抓取 PubMed 元数据生成;标题与摘要版权归原作者与期刊所有;机译内容仅供参考,请以英文原文为准;收录不代表本站观点,亦不作为用药或医疗建议。